Rubric Capital Management LP - Jun 17, 2024 Form 4 Insider Report for Mereo BioPharma Group plc (MREO)

Role
10%+ Owner
Signature
Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer
Stock symbol
MREO
Transactions as of
Jun 17, 2024
Transactions value $
$6,999,857
Form type
4
Date filed
6/17/2024, 05:16 PM
Previous filing
Jan 2, 2024
Next filing
Jul 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MREO American Depositary Shares ("ADSs") Award $7M +1.75M +12.94% $3.99 15.3M Jun 17, 2024 Ordinary Shares, GBP 0.003 par value per share See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each ADS represents five (5) Ordinary Shares, GBP 0.003 par value per share ("Ordinary Shares")
F2 This Form 3 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
F3 N/A

Remarks:

The Reporting Persons are directors by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Justin Roberts, a Partner at Rubric Capital, serves on the board of directors of the Issuer.